RR1 -- waiting for assay results
M3M ann -- RC DRILLING PROGRAM COMMENCES AT EDJUDINA GOLD PROJECT
GGE ann -- Jesse-1A re-entry schedule for December 2023
MTM ann -- MTM secures $1 million Investment highlights
ETR ann -- Presentation - Bell Potter Environmental Conference -Invested in excess of $40m over 12 years developing Company owned patented thermal process
Stapylton facility has processed more than 2 million tyres on site
Tightening regulations are demanding alternate solutions and driving increased opportunities
Significant infrastructure investments – latest upgrades to Stapylton nearing completion
Significant interest from potential global strategic partners aligned with strategic plan
Offtake volumes secured, including domestic and international customers
Extensive IP Portfolio with patents awarded enabling international expansion opportunities
The Company is well positioned to emerge as a global leader over the next 12 months
- Forums
- ASX - Day Trading
- Morning Trading November 22
Morning Trading November 22, page-18
-
- There are more pages in this discussion • 276 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online